Vancomycin + D5W (Dextrose 5% in Water) Compatibility

Approved Diluents for Vancomycin

Key Preparation Points

• Reconstitution: Vancomycin powder is first reconstituted with Sterile Water for Injection (10 mL per 500 mg vial, 20 mL per 1 g vial).
• Further dilution: The reconstituted solution is then diluted in at least 100–250 mL of D5W or NS for IV infusion.
• Concentration: Final concentration should generally not exceed 5 mg/mL (some sources allow up to 10 mg/mL for fluid-restricted patients, but higher concentrations increase infusion-related reactions).

Stability in D5W

• At room temperature: stable for 24 hours after dilution in D5W.
• Under refrigeration (2–8°C): stable for up to 14 days in D5W (per manufacturer labeling and Trissel's Handbook on Injectable Drugs).
• Inspect visually for particulate matter or discoloration before use.

Clinical Considerations

• Infusion rate: Vancomycin must be infused slowly — typically over at least 60 minutes (for doses ≤1 g) to minimize the risk of Red Man Syndrome (infusion-related flushing, erythema, hypotension caused by rapid infusion, not a true allergy).
• For doses >1 g, infuse over 90–120 minutes or longer.
• D5W is particularly useful in patients on sodium-restricted diets where NS would be less ideal.

Incompatibilities to Avoid

• Beta-lactam antibiotics (e.g., piperacillin-tazobactam — precipitation can occur)
• Heparin (at certain concentrations)
• Albumin
• Alkaline solutions (pH-dependent precipitation)

Fluconazole + D5W Compatibility

Compatible Diluents

Key Administration Points

• Pre-mixed bags: IV fluconazole is typically supplied as a 2 mg/mL solution in 100 mL (200 mg) or 200 mL (400 mg) bags — no further dilution needed.
• Infusion rate: Administer at a maximum rate of 200 mg/hour (do not exceed this due to risk of adverse effects including hypotension, arrhythmias).
• The solution should be clear and colorless to pale yellow — do not use if particulate matter or unusual discoloration is present.

Stability in D5W

• Commercially prepared fluconazole in D5W is stable through the manufacturer's labeled expiration date.
• If repackaged or compounded: generally stable for 24 hours at room temperature or 72 hours refrigerated (verify with pharmacy for compounded preparations).

Important Incompatibilities

• Amphotericin B (precipitates)
• Calcium gluconate
• Ceftriaxone
• Clindamycin
• Diazepam
• Erythromycin
• Furosemide (at certain concentrations)
• Trimethoprim-sulfamethoxazole

Phenobarbital + D5W Compatibility

Compatible Diluents

Key Administration Points

• Dilution: Phenobarbital sodium injection should be further diluted before IV administration. Do not administer undiluted or as a rapid IV bolus.
• Concentration: Keep the final concentration as low as feasible. High concentrations increase the risk of precipitation and tissue irritation.
• Infusion rate: Must not exceed 60 mg/min IV (many sources recommend ≤30 mg/min) to avoid respiratory depression, hypotension, and cardiovascular collapse. In pediatrics, the rate is typically ≤1 mg/kg/min.
• Filter: Use of a 0.22-micron inline filter is recommended — phenobarbital can precipitate, especially when mixed with other drugs.

Stability in D5W

• Generally stable for 24 hours at room temperature once diluted, but use as soon as possible after preparation.
• Phenobarbital is highly pH-sensitive — it is alkaline (pH ~9–10), and mixing with acidic solutions or drugs can cause precipitation.
• Avoid exposure to light during storage.

Important Incompatibilities

• Acidic drugs: Morphine, hydromorphone, opioids in general — precipitation risk
• Phenytoin — do not mix
• Atracurium
• Cimetidine
• Chlorpromazine
• Ephedrine
• Hydralazine
• Insulin
• Ranitidine (concentration-dependent)
• Most penicillins and cephalosporins

Bottom Line

Phenobarbital + D10W (Dextrose 10% in Water)

What We Know

• Phenobarbital compatibility studies are most commonly performed and cited with D5W and NS — these are the diluents listed in manufacturer labeling and standard references (Trissel's, King Guide).
• D10W is not a standard or recommended diluent for phenobarbital in published compatibility literature.
• Dextrose concentration itself (5% vs 10%) does not typically cause direct chemical incompatibility with phenobarbital, but the lack of formal stability data for D10W means it cannot be recommended as a safe diluent.

General Principle

Recommendation

Fluconazole + D10W

Approved vs. Unapproved Diluents

Why This Matters

• Fluconazole's stability is pH and concentration-dependent. Studies have only been conducted in the standard diluents listed above.
• The higher osmolality of D10W compared to D5W has not been formally evaluated in the context of fluconazole stability.
• Absence of data means compatibility cannot be assumed.

Recommendation

Vancomycin + D10W Compatibility

Approved vs. Unapproved Diluents

What We Know

• Vancomycin is chemically stable across a relatively broad pH range (3.0–5.0 in solution), and dextrose concentration changes alone are unlikely to cause direct chemical degradation.
• However, formal stability and compatibility studies for vancomycin in D10W are not well published in standard references (Trissel's, King Guide, manufacturer PI).
• Some institutional and compounding pharmacies have used D10W in specific clinical contexts (e.g., neonates requiring concurrent glucose delivery), but this is not standard practice and relies on pharmacist judgment rather than peer-reviewed stability data.

Recommendation

1. Capnea (caspofungin) — an antifungal medication?
2. Capnia / hypercapnia — a condition related to elevated CO₂?
3. Something else entirely?

Caffeine Citrate Injection + D10W

Compatible Diluents

Key Points

• Caffeine citrate (Cafcit) is commercially available as a 20 mg/mL solution (10 mg/mL caffeine base) — can be used undiluted or further diluted.
• It is commonly diluted in D10W in neonatal ICUs, as neonates often receive D10W as their maintenance fluid and caffeine citrate can be piggy-backed or mixed directly.
• The solution is acidic (pH ~4.7) and remains stable in dextrose-containing solutions.
• No preservatives in the commercial formulation — use within the labeled time after opening.

Stability

• Stable for 24 hours at room temperature once diluted in compatible IV solutions.
• Protect from excessive heat; store at controlled room temperature.

Incompatibilities

• Acyclovir — precipitation reported
• Furosemide — incompatible
• Lorazepam — incompatible
• Nitroglycerin — incompatible
• Oxacillin — incompatible
• Pantoprazole — incompatible

Clinical Note